CYCLHAD
-
Approval date
28 September 2018
-
Borrower
SAS CYCLHAD
- Country
-
Loan size
€ 42 000 000
-
Line of action
Sustainable and inclusive growth
-
Status
Completed
An additional loan request to part-finance the acquisition and exploitation of the System of Research and Treatment in Hadrontherapy (SRTH) prototype. Final beneficiairies will be people affected by cancer, who will have access to an innovative cancer treatment therapy.